Italian study tracks Real-World treatment of painful uterine condition
NCT ID NCT07478614
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 200 women aged 20-50 with adenomyosis, a condition causing pelvic pain and heavy bleeding. Researchers will observe which treatments doctors prescribe and how well they work over 12 months. The goal is to understand current medical practices and help develop better treatment guidelines.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help create clearer guidelines for treating adenomyosis, improving care and quality of life for affected women.
- What could go wrong
- This is an observational study, not testing a new treatment. It only describes current practices, so it won't directly lead to a cure or new therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
Feb 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Female patients aged between 20 and 50 years, symptomatic for adenomyosis, with a confirmed diagnosis.
- Ages
-
20 to 50 years
- Sex
-
Female participants only
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Age between 20 and 50 years; Instrumental (ultrasound or MRI) and/or histological diagnosis of adenomyosis; Adenomyosis-associated pain with a VAS score ≥ 4 and/or presence of heavy menstrual bleeding (HMB) defined as a score \> 100 on the Pictorial Blood Assessment Chart (PBAC); Provision of written informed consent to participate in the study; Willingness to be followed at the participating center for the entire duration of the study. Exclusion Criteria: Current or previous clinical and/or instrumental diagnosis of endometriosis; Suspected or confirmed pregnancy; Inability to understand the purpose of the study and to provide informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Adenomyosis of uterus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Ospedale San Carlo
RECRUITINGPotenza, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI learn to spot endometriosis and fibroids on ultrasound?
- Sound waves vs. uterine pain: can HIFU calm adenomyosis?
- Can a water barrier make microwave ablation safer for the womb?
- A simple diet and muscle relaxant may sharpen views in scarless hysterectomy
- Could a fibroid drug help women with adenomyosis finally achieve a live birth?
- Could a common muscle relaxant cut narcotic use after hysterectomy?